The genus Psilocybe currently comprises approximately 165 species that are hallucinogenic. Chemical studies on them have revealed the presence of alkaloids with indole and β-carboline structures, which are responsible for their psychotropic properties. However, scarce information has been reported on other classes of metabolites present in Psilocybe mushrooms. The objective of this review was...
Mushroom use dates back to ancient times, and it currently remains significant among indigenous and urban populations as a medicinal option. Psilocybe species are suggested to modify emotions when administered in macro- or microdose form for the treatment of anxiety and depression, both often affected by a delayed onset and adverse effects of current pharmacological therapy. The objective of...
Central nervous system (CNS) diseases can be diverse and usually present with comorbidity, as in the case of depression and anxiety. Despite alternatives like Psilocybe mushrooms for mental health there is no basic research to evidence their CNS benefits. To evaluate the anxiolytic- and antidepressant-like effects, as well as the acute toxicity of P. cubensis mushroom. First, the acute toxicity...
En las últimas dos décadas se han realizado diversas investigaciones para dilucidar los efectos terapéuticos de la psilocibina en el cuerpo y la mente de los seres humanos. Uno de los propósitos de este artículo es mostrar que no existe una oposición excluyente entre ciencia y espiritualidad. Para ello es importante reflexionar de manera crítica sobre los marcos conceptuales utilizados...